Magy Laurent

15PUBLICATIONS
124CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Gene and molecular therapyPredictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 30, 2026
Rituximab With or Without Chemotherapy for Anti-MAG Neuropathy: A Retrospective Multicenter Real-World Study.

|Sep 26, 2026
Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.

|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

|May 05, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

|Jul 30, 2025
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Antoine Gavoille, Emmanuelle Leray, Romain Marignier

|Jul 16, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Camille Robin, Fabien Rollot, Mathilde Lefort

Pageof 3

Frequent Collaborators

7 joint publications

David-Axel Laplaud

7 joint publications

Christine Lebrun-Frénay

7 joint publications

Aurélie Ruet

7 joint publications

Laure Michel